Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease

Keyphrases

• Agreed Definition 14%
• Alcohol 100%
• Alcohol Consumption 14%
• Alcohol Use 14%
• Alcoholic Hepatitis 14%
• Alcoholic Liver Disease 14%
• All Diseases 14%
• Atherogenic Dyslipidemia 14%
• Cardiometabolic Risk 42%
• Cardiovascular Disease 14%
• Cause of Illness 14%
• Causes of Mortality 14%
• Chronic Kidney Disease 14%
• Clinical Conditions 14%
• Disease Spectrum 14%
• Extrahepatic Complications 14%
• Fatty Liver 14%
• Global Obesity 14%
• Global Types 14%
• Hepatocellular Carcinoma 14%
• Hypertension 14%
• Inflammation 14%
• Kidney Malignancy 14%
• Liver Disease 57%
• Liver Disease Progression 14%
• Liver Fibrosis 14%
• Metabolic 100%
• Metabolic-associated Fatty Liver Disease (MAFLD) 100%
• Rapid Progression 14%
• Rapid Rise 14%
• Risk Factors 100%
• Risk Level 14%
• Severe Outcomes 14%
• Steatotic Liver Disease 100%
• Susceptible Individuals 14%
• Type 2 Diabetes Mellitus (T2DM) 14%
• Westernized Lifestyle 14%
• World Population 14%

Medicine and Dentistry

• Alcohol Consumption 20%
• Cancer 10%
• Cardiometabolic Risk 30%
• Cardiovascular Disease 10%
• Chronic Kidney Disease 10%
• Disease 30%
• Disease Exacerbation 10%
• Dyslipidemia 10%
• Fatty Liver 10%
• Hepatocellular Carcinoma 10%
• Injury 10%
• Liver Disease 100%
• Liver Fibrosis 10%
• Maturity Onset Diabetes of the Young 10%
• Metabolic Dysfunction-Associated Steatotic Liver Disease 69%
• Prevalence 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 5%
• Chronic Kidney Failure 5%
• Disease 17%
• Disease Exacerbation 5%
• Dyslipidemia 5%
• Ethanol 100%
• Fatty Liver 5%
• Inflammation 5%
• Injury 5%
• Liver Cell Carcinoma 5%
• Liver Disease 100%
• Liver Fibrosis 5%
• Non Insulin Dependent Diabetes Mellitus 5%
• Prevalence 11%